UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Accuracy and Relative Value of Bone Marrow Aspiration in the Detection of Lymphoid Infiltration in non-Hodgkin Lymphoma

Tumori, 2010, Vol.96 (1), p.24-27

2010

Volltextzugriff (PDF)

Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma

Cancer, 2011-03, Vol.117 (5), p.964-973

2011

Volltextzugriff (PDF)

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

European journal of nuclear medicine and molecular imaging, 2023-01, Vol.50 (2), p.572-580

2023

Volltextzugriff (PDF)

Adequacy of endosonography‐derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer

The clinical respiratory journal, 2019-09, Vol.13 (9), p.590-597

2019

Volltextzugriff (PDF)

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.234-242

2015

Volltextzugriff (PDF)

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

Journal of cancer research and clinical oncology, 2014-10, Vol.140 (10), p.1783-1793

2014

Volltextzugriff (PDF)

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients

Diagnostic cytopathology, 2015-11, Vol.43 (11), p.941-946

2015

Volltextzugriff (PDF)

Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer

Tumori, 1985-06, Vol.71 (3), p.297-300

1985

Volltextzugriff (PDF)

Asymptomatic Pulmonary Embolism in Lung Cancer: Prevalence and Analysis of Clinical and Radiological Characteristics in 141 Outpatients

Tumori, 2012-09, Vol.98 (5), p.594-600

2012

Volltextzugriff (PDF)

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.e690-e698

2024

Volltextzugriff (PDF)

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Cancer treatment reviews, 2018-12, Vol.71, p.76-87

2018

Volltextzugriff (PDF)

Biologic and clinical effects of continuous infusion interleukin‐2 in patients with non‐small cell lung cancer

Cancer, 1994-03, Vol.73 (5), p.1353-1360

1994

Volltextzugriff (PDF)

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

The lancet oncology, 2014-07, Vol.15 (8), p.e304-e304

2014

Volltextzugriff (PDF)

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Breast (Edinburgh), 2007-06, Vol.16 (3), p.280-292

2007

Volltextzugriff (PDF)

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

Breast cancer research and treatment, 2005-05, Vol.91 (2), p.203-205

2005

Volltextzugriff (PDF)

c-erbB-2 protein in serum of primary lung cancer patients

Cancer detection and prevention, 2002-01, Vol.26 (1), p.64-68

2002

Volltextzugriff (PDF)

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1283-1289

2019

Volltextzugriff (PDF)

CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients

Tumor biology, 2015-08, Vol.36 (8), p.5943-5951

2015

Volltextzugriff (PDF)

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.153-163

2019

Volltextzugriff (PDF)

Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Journal of clinical oncology, 1996-03, Vol.14 (3), p.814-820

1996

Volltextzugriff (PDF)

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab

Immunotherapy, 2018-06, Vol.10 (8), p.681-694

2018

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.286-286

2013

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.285

2013

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(138)

Sprache

Englisch
(138)

Erscheinungsjahr

n.n

Thema

Humans
(138)
Science & Technology
(128)
Life Sciences & Biomedicine
(125)
Middle Aged
(103)
Oncology
(103)
Male
(102)
Aged
(99)
Adult
(72)
Lung Neoplasms - Drug Therapy
(59)
Lung Neoplasms - Pathology
(51)
Aged, 80 And Over
(48)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(45)
Treatment Outcome
(41)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Carcinoma, Non-Small-Cell Lung - Pathology
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Neoplasm Staging
(30)
Chemotherapy
(28)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(19)
Tumori
(13)
Journal Of Clinical Oncology
(9)
Cancer
(7)
American Journal Of Clinical Oncology
(6)
Anticancer Research
(5)
Journal Of Thoracic Oncology
(5)
Clinical Lung Cancer
(4)
The New England Journal Of Medicine
(4)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Accuracy and Relative Value of Bone Marrow Aspiration in the Detection of Lymphoid Infiltration in non-Hodgkin Lymphoma

Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

Adequacy of endosonography‐derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients

Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer

Asymptomatic Pulmonary Embolism in Lung Cancer: Prevalence and Analysis of Clinical and Radiological Characteristics in 141 Outpatients

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Biologic and clinical effects of continuous infusion interleukin‐2 in patients with non‐small cell lung cancer

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

c-erbB-2 protein in serum of primary lung cancer patients

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer

Colony-stimulating factors for febrile neutropenia

Colony-stimulating factors for febrile neutropenia

Aktive Filter

Suchergebnisse filtern